| 产品详情 |
| Edit |   |
|---|
| Product Name | SB216763 (3-(2,4-dichlorophenyl)-4-(1-methylindol-3-yl)pyrrole- 2,5-dione) |
|---|
| Description | Highly Purified (~98%). The maleimide derivative SB216763 is a potent and selective cell permeable inhibitor of glycogen synthase kinase 3 (GSK-3). Research studies using peptide-based protein kinase assays show that SB216763 inhibits GSK-3alpha in an ATP competitive manner with an IC50 of 34nM, and is an equally effective GSK3-B inhibitor. Similar assays demonstrate that SB216763 (at concentrations up to 10uM) does not inhibit as many as 24 other serine/threonine and tyrosine protein kinases (1). As a consequence of inhibiting GSK-3, SB216763 stimulates glycogen synthesis in human liver cells (EC50 3.6uM) via glycogen synthase activation and induces expression of a B-catenin regulated reporter gene in HEK293 cells (1). Furthermore, SB216763 induces accumulation of B-catenin, a key downstream effector in the Wnt signaling pathway, in many cell types (2-5). Additional research indicates that SB216763 can prevent neuronal cell death induced by PI3 kinase pathway inhibition (2). Glycogen synthase kinase 3 inhibi |
|---|
| Size | 5mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 351908 |
|---|
| Price | |
|---|
| Order / More Info | SB216763 (3-(2,4-dichlorophenyl)-4-(1-methylindol-3-yl)pyrrole- 2,5-dione) from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|